By Ben Hubbard The New York Times Mon., Dec. 17, 2018 Saudi Arabia lashed out Monday at the U.S. Senate for holding the crown prince, Mohammed bin Salman, personally responsible for the murder of a Saudi dissident in Istanbul, warning against interference in what it called the kingdom’s internal affairs. The unusually strong statement aimed at a branch of the U.S. government was the kingdom’s first response to a Senate resolution passed last week that blames Crown Prince Mohammed for the death and dismemberment of Jamal Khashoggi inside the Saudi Consulate in Istanbul. It was also the kingdom’s latest attempt to manage the damage the killing has done to its decades-old alliance with the United States. The Oct. 2 murder of Khashoggi by Saudi agents has prompted the most serious crisis in U.S.-Saudi relations in more than a decade, pushing a range of U.S. officials to call for limits on U.S. military co-operation or arms sales to the kingdom. Last … [Read more...] about Saudi Arabia denounces U.S. Senate’s response to Khashoggi murder
U s adoption agencies
By Jay Greene The Wall Street Journal Sat., Sept. 8, 2018 A handful of tech giants are invoking one of the White House’s priorities—leadership in an emerging wireless technology known as 5G—to argue against adding tariffs on $200 billion (U.S.) in goods coming from China. Intel Corp., Cisco Systems Inc., Dell Technologies Inc. and other tech companies are seeking to convince the U.S. Trade Representative to nix plans to place tariffs on products they say are vital to rolling out fifth-generation wireless services in the U.S. By raising costs for the goods required to build 5G networks, the proposed tariffs “will slow down the pace of technology adoption across the U.S. economy, causing American firms and institutions to fall behind foreign competitors outside of China that aren’t subject to the same tariffs,” Intel wrote in comments filed with the agency late Thursday. The tariffs appear to run counter to the White House’s … [Read more...] about Tech firms say China tariffs will set back U.S.’s 5G goals
By Mark Mazzetti and Mark Landler The New York Times Sun., June 17, 2018 WASHINGTON—An American financier approached the Trump administration last summer with an unusual proposition: The North Korean government wanted to talk to Jared Kushner, the president’s son-in-law and senior adviser. The financier, Gabriel Schulze, explained that a top North Korean official was seeking a back channel to explore a meeting between U.S. President Donald Trump and Kim Jong Un, who for months had traded threats of military confrontation. Schulze, who lives in Singapore, had built a network of contacts in North Korea on trips he had taken to develop business opportunities in the isolated state. For some in North Korea, which has been ruled since its founding by a family dynasty, Kushner appeared to be a promising contact. As a member of the president’s family, officials in Pyongyang judged, Kushner would have the ear of his father-in-law and be immune from the … [Read more...] about How a U.S. financier with White House connections to Jared Kushner led to the handshake deal between Trump and Kim
By Jesse McLean Investigative Reporter Thu., May 3, 2018 Purdue Pharma, the maker of OxyContin, paid Canadian doctors nearly three-and-a-half times more money than it doled out to U.S. prescribers, according to a Star analysis of the drug maker’s physician payments adjusted for the countries’ populations. Purdue Canada gave just over $2 million to Canadian health-care professionals in 2016 for services such as consulting and delivering speeches on conditions and treatments. That same year, U.S.-based Purdue Pharma L.P. paid American physicians $5.53 million (Canadian), according to a U.S. government database showing the financial ties between Big Pharma and prescribers. (2016 is the only year payment data is publicly available for both countries.) That means for every 1,000 residents, Purdue spent $58 on Canadian doctors compared to $17 in the U.S. Another way to look at it: Purdue gave $24 for every Canadian physician, while its U.S. operations … [Read more...] about Why did the maker of OxyContin pay Canadian doctors nearly three-and-a-half times more money per capita than it doled out to U.S. prescribers?
By Greg Stohr Bloomberg Wed., April 25, 2018 The U.S. Supreme Court will directly confront U.S. President Donald Trump’s travel ban for the first time with arguments being made Wednesday in a case that could redefine the president’s power to control the nation’s borders. More than four months after letting the ban take full effect during the litigation, the justices will weigh opponents’ contentions that the policy unconstitutionally singles out Muslims while doing little to prevent terrorism. The policy restricts entry by more than 150 million people from seven countries, five of them predominantly Muslim. It’s the third version of a ban that triggered chaos and protests at American airports when Trump signed the first executive order a week after taking office. Read more: U.S. appeals court declares Trump travel ban unconstitutional Article Continued Below Out of chaos, Trump has reshaped U.S. immigration After Supreme … [Read more...] about Trump’s travel ban reaches U.S. Supreme Court